Gene · 3660
Papers2,395
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,395
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Abstracts from the 13th International Conference for Healthcare and Medical Students (ICHAMS). | BMC Proc | 2025 | 40033387 | PubTator, text mining | PubMed |
| Omics Investigations of Prostate Cancer Cells Exposed to Simulated Microgravity Conditions. | Biomolecules | 2025 | 40001606 | PubTator, text mining | PubMed |
| The IRF2-INPP4B Pathway Aggravates Acute Myeloid Leukemia | Turk J Haematol | 2025 | 39960210 | PubTator, text mining | PubMed |
| Therapeutic potential of targeting the IRF2/POSTN/Notch1 axis in nucleus pulposus cells for intervertebral disc degeneration. | J Neuroinflammation | 2025 | 39844302 | PubTator, text mining | PubMed |
| Exosomal miR-184 facilitates bladder cancer progression by targeting AKR1C3 and inducing immune escape via IRF2-CXCL10 axis. | Biochim Biophys Acta Mol Basis Dis | 2025 | 39689761 | PubTator, text mining | PubMed |
| CircPCNXL2 promotes preeclampsia progression by suppressing trophoblast cell proliferation and invasion via miR-487a-3p/interferon regulatory factor 2 axis. | J Hypertens | 2025 | 39466687 | PubTator, text mining | PubMed |
| Epigenetic Adaptation Drives Monocyte Differentiation into Microglia-Like Cells Upon Engraftment into the Central Nervous System. | bioRxiv | 2025 | 39314467 | PubTator, text mining | PubMed |
| MetArea: a software package for analysis of the mutually exclusive occurrence in pairs of motifs of transcription factor binding sites based on ChIP-seq data. | Vavilovskii Zhurnal Genet Selektsii | 2024 | 39944799 | PubTator, text mining | PubMed |
| Identification of ALEKSIN as a novel multi-IRF inhibitor of IRF- and STAT-mediated transcription in vascular inflammation and atherosclerosis. | Front Pharmacol | 2024 | 39840103 | PubTator, text mining | PubMed |
| IRF2BP2 binds to a conserved RxSVI motif of protein partners and regulates megakaryocytic differentiation. | Nat Commun | 2024 | 39616187 | PubTator, text mining | PubMed |
| Interplay between Two Paralogous Human Silencing Hub (HuSH) Complexes in Regulating LINE-1 Element Silencing. | Nat Commun | 2024 | 39489739 | Swiss-Prot, curated | PubMed |
| A CRISPR-Cas9 knockout screening identifies IRF2 as a key driver of OAS3/RNase L-mediated RNA decay during viral infection. | Proc Natl Acad Sci U S A | 2024 | 39475651 | PubTator, text mining | PubMed |
| IRF2 loss is associated with reduced MHC I pathway transcripts in subsets of most human cancers and causes resistance to checkpoint immunotherapy in human and mouse melanomas. | J Exp Clin Cancer Res | 2024 | 39354629 | PubTator, text mining | PubMed |
| Expression Characteristics, Immune Signature, and Prognostic Value of the SOCS Family Identified by Multiomics Integrative Analysis in Liver Cancer. | Cancer Rep (Hoboken) | 2024 | 39307915 | PubTator, text mining | PubMed |
| [Prevalence of dermatological manifestations in common variable immunodeficiency patients]. | Rev Alerg Mex | 2024 | 39298120 | PubTator, text mining | PubMed |
| Transcriptomic response of lumpfish (Cyclopterus lumpus) head kidney to viral mimic, with a focus on the interferon regulatory factor family. | Front Immunol | 2024 | 39211041 | PubTator, text mining | PubMed |
| Gene Regulatory Network Analysis of Decidual Stromal Cells and Natural Killer Cells. | Reprod Sci | 2024 | 39090334 | PubTator, text mining | PubMed |
| Novel hypermorphic variants in IRF2BP2 identified in patients with common variable immunodeficiency and autoimmunity. | Clin Immunol | 2024 | 39059757 | PubTator, text mining | PubMed |
| Unraveling epigenomic signatures and effectiveness of electroconvulsive therapy in treatment-resistant depression patients: a prospective longitudinal study. | Clin Epigenetics | 2024 | 39020437 | PubTator, text mining | PubMed |
| Competition between two HUSH complexes orchestrates the immune response to retroelement invasion. | Mol Cell | 2024 | 39013473 | Swiss-Prot, curated | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3660/papers?page=4